Exposure to diagnostic radiological procedures and the risk of childhood acute lymphoblastic leukemia

- Bailey, Helen D., Armstrong, Bruce K., De Klerk, Nicholas H., Fritschi, Lin, Attia, John R., Lockwood, Liane, Milne, Elizabeth, Aus-ALL Consortium,

Nucleotide excision repair gene expression after cisplatin treatment in melanoma

- Bowden, Nikola A., Ashton, Katie A., Kiejda, Kelly A., Zhang, Xu Dong, Hersey, Peter, Scott, Rodney J.

Antiproliferative effects of continued mitogen-activated protein kinase pathway inhibition following acquired resistance to BRAF and/or MEK inhibition in melanoma

- Carlino, Matteo S., Gowrishankar, Kavitha, Rizos, Helen, Saunders, Catherine A. B., Pupo, Gulietta M., Snoyman, Stephanie, Zhang, Xu Dong, Saw, Robyn, Becker, Therese M., Kefford, Richard F., Long, Georgina V.

Inhibition of endoplasmic reticulum stress-induced apoptosis of melanoma cells by the ARC protein

- Chen, Li Hua, Jiang, Chen Chen, Watts, Ralph, Thorne, Rick F., Kiejda, Kelly A., Zhang, Xu Dong, Hersey, Peter

Inhibition of dynamin by dynole 34-2 induces cell death following cytokinesis failure in cancer cells

- Chircop, Megan, Perera, Swetha, Sakoff, Jennette, O'Brien, Terence J., McCluskey, Adam, Robinson, Phillip J., Mariana, Anna, Lau, Hui, Ma, Maggie P. C., Gilbert, Jayne, Jones, Nigel C., Gordon, Christopher P., Young, Kelly A., Morokoff, Andrew

Genetic ablation of the tetraspanin CD151 reduces spontaneous metastatic spread of prostate cancer in the TRAMP model

- Copeland, Ben T., Bowman, Matthew J., Ashman, Leonie K.

An in vivo tumor model exploiting metabolic response as a biomarker for targeted drug development

- Cullinane, Carleen, Dorow, Donna S., Kansara, Maya, Conus, Nelly, Binns, David, Hicks, Rodney J., Ashman, Leonie Kay, McArthur, Grant A., Thomas, David M.

Estrogen receptor expression in 21-gene recurrence score predicts increased late recurrence for estrogen-positive/HER2-negative breast cancer

- Dowsett, Mitch, Sestak, Ivana, Buus, Richard, Lopez-Knowles, Elena, Mallon, Elizabeth, Howell, Anthony, Forbes, John F., Buzdar, Aman, Cuzick, Jack

Juxtamembrane mutant V560GKit is more sensitive to Imatinib (ST1571) compared with wild-type c-Kit whereas the kinase domain mutant D816VKit is resistant

- Frost, Michelle J., Ferrao, Petranel T., Hughes, Timothy P., Ashman, Leonie K.

Colocalization of the tetraspanins, CO-029 and CD151, with integrins in human pancreatic adenocarcinoma: Impact on cell motility

- Gesierich, S., Paret, C., Hildebrand, D., Weitz, J., Zgraggen, K., Schmitz-Winnenthal, F. H., Horejsi, V., Yoshie, O., Herlyn, D., Ashman, Leonie K., Zoller, M.

Folate pathway gene polymorphisms and risk of childhood brain tumors: results from an Australian case-control study

- Greenop, Kathryn R., Scott, Rodney J., Ashton, Lesley J., Armstrong, Bruce K., Milne, Elizabeth, Attia, John, Bower, Carol, de Klerk, Nicholas H., Norris, Murray D., Haber, Michelle, Jamieson, Sarra E., van Bockxmeer, Frank M., Gottardo, Nicholas G.

Metabolic approaches to treatment of melanoma

- Hersey, Peter, Watts, Ralph Neal, Zhang, Xu Dong, Hackett, John

Up-regulation of Mcl-1 is critical for survival of human melanoma cells upon endoplasmic reticulum stress

- Jiang, Chen Chen, Lucas, Keryn, Avery-Kiejda, Kelly A., Wade, Margaret, deBock, Charles E., Thorne, Rick F., Allen, John, Hersey, Peter, Zhang, Xu Dong

MEK-independent survival of B-RAFV600E melanoma cells selected for resistance to apoptosis induced by the RAF inhibitor PLX4720

- Jiang, Chen Chen, Lai, Fritz, Thorne, Rick F., Yang, Fan, Liu, Hao, Hersey, Peter, Zhang, Xu Dong

Nerve-cancer cell cross-talk: a novel promoter of tumor progression

- Jobling, Phillip, Pundavela, Jay, Oliveira, Sonia M. R., Roselli, Séverine, Walker, Marjorie M., Hondermarck, Hubert

The dynamin inhibitors MiTMAB and OcTMAB induce cytokinesis failure and inhibit cell proliferation in human cancer cells

- Joshi, Sanket, Perera, Swetha, Chircop, Megan, Gilbert, Jayne, Smith, Charlotte M., Mariana, Anna, Gordon, Christopher P., Sakoff, Jennette A., McCluskey, Adam, Robinson, Phillip J., Braithwaite, Antony W.

Phase II trial of tremelimumab (CP-675,206) in patients with advanced refractory or relapsed melanoma

- Kirkwood, John M., Lorigan, Paul, Hersey, Peter, Hauschild, Axel, Robert, Caroline, McDermott, David, Marshall, Margaret A., Gomez-Navarro, Jesus, Liang, Jane Q., Bulanhagui, Cecile A.

A p53-responsive miRNA network promotes cancer cell quiescence

- La, Ting, Liu, Guang Zhi, Guo, Su Tang, Liu, Tao, Thorne, Rick F., Jin, Lei, Zhang, Xu Dong, Farrelly, Margaret, Cole, Nicole, Feng, Yu Chen, Zhang, Yuan Yuan, Sherwin, Simonne K., Yari, Hamed, Tabatabaee, Hessam, Yan, Xu Guang

RIP1 kinase is an oncogenic driver in melanoma

- Liu, Xiao Ying, Lai, Fritz, Jin, Lei, Zhang, Xu Dong, Yan, Xu Guang, Jiang, Chen Chen, Guo, Su Tang, Wang, Chun Yan, Croft, Amanda, Tseng, Hsin-Yi, Wilmott, James S., Scolyer, Richard A.

Genome-wide association study identifies a possible susceptibility locus for endometrial cancer

- Long, Jirong, Zheng, Wei, Dubrowinskaja, Natalia, Goodman, Marc T., Salvesen, Helga B., Fasching, Peter A., Scott, Rodney J., Delahanty, Ryan, Zheng, Ying, O'Mara, Tracy, Healey, Catherine S., Hodgson, Shirley, Xiang, Yong-Bing, Risch, Harvey, Yang, Hannah P., Amant, Frederic, Turmanov, Nurzhan, Schwake, Anita, Lurie, Galina, Trovik, Jone, Beckmann, Matthias W., Ashton, Katie, Ji, Bu-Tian, Lose, Felicity, Bao, Ping-Ping, Howarth, Kimberly, Lu, Lingeng, Lissowska, Jolanta, Coenegrachts, Lieve, Kaidarova, Dilyara, Dürst, Matthias, Thompson, Pamela J., Krakstad, Camilla, Ekici, Arif B., Thompson, Deborah, Otton, Geoffrey, Shi, Jiajun, Zhang, Ben, Gorman, Maggie, Brinton, Louise, Coosemans, An, Matsuno, Rayna K., Halle, Mari K., Hein, Alexander, Proietto, Anthony, Tomlinson, Ian, Cai, Hui, Lu, Wei, Dunning, Alison, Easton, Douglas, Gao, Yu-Tang, Cai, Qiuyin, Spurdle, Amanda B., Shu, Xiao-Ou, Yu, Herbert, Wentzensen, Nicholas, Lambrechts, Diether, Dörk, Thilo